Prudential Financial
DNA icon

Prudential Financial’s Ginkgo Bioworks DNA Stock Holding History

Prudential Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,418
Closed -$18.7K – 2730
2024
Q2 		$18.7K Sell
1,418
-585
-29% -$17.5K ﹤0.01% 2669
2024
Q1 		$92.9K Buy
2,003
+1
+0% +$52 ﹤0.01% 2535
2023
Q4 		$135K Buy
2,002
+380
+23% +$23.3K ﹤0.01% 2480
2023
Q3 		$117K Buy
1,622
+192
+13% +$15.3K ﹤0.01% 2437
2023
Q2 		$106K Buy
1,430
+298
+26% +$17.6K ﹤0.01% 2477
2023
Q1 		$108K Buy
1,132
+259
+30% +$16.4K ﹤0.01% 2446
2022
Q4 		$59K Sell
873
-11
-1% -$1.01K ﹤0.01% 2483
2022
Q3 		$84K Buy
884
+59
+7% +$7.03K ﹤0.01% 2525
2022
Q2 		$96K Buy
825
+459
+125% +$56K ﹤0.01% 2534
2022
Q1 		$59K Buy
366
+21
+6% +$4.09K ﹤0.01% 2563
2021
Q4 		$115K Buy
+345
New +$164K ﹤0.01% 2574

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Prudential Financial's DNA Position: Q3 2024 in Review

Prudential Financial sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 1,418 shares — an estimated $18.7K sold.

Prudential Financial first reported a position in DNA in Q4 2021 and held it in 11 quarters. The position peaked at $135K in Q4 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Prudential Financial reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Prudential Financial sold 1,418 Ginkgo Bioworks shares in Q3 2024, an estimated $18.7K.
  • Prudential Financial first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 11 quarters.
  • Prudential Financial's Ginkgo Bioworks position peaked at $135K in Q4 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.